RE: Plenty of cash6 Nov 2015 12:43
Cash, cash equivalents and money held on deposits at the half year-end was £24.1m (2014: £8.2m). At the period end, a total of £15.0m (2014: £nil) has been placed on deposit across different banks, all with strong credit ratings. The maturity profiles of these deposits range from nine to 12 months.
The Company raised gross proceeds of £20.0m from a placing of new ordinary shares at a price of 10 pence per share in June 2015 to certain existing and new institutional shareholders. Issue costs associated with the placing were £0.56m. The additional funds enable the Company to proceed along its clinical pathway with confidence and also allows the expansion of the pipeline. Cash management and tight cost control continue to be a priority for the business and the additional funds raised will not change this mentality